Chester County News and Community Website
WASHINGTON, D.C. — On Friday, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between the completion of …
Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that this week it has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to:
Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that the U.S. Food and Drug Administration (FDA) recently provided authorization to proceed for INOVIO’s INNOVATE Phase 3 Segment for its COVID-19 …
Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that it recently received authorization from India’s Central Drugs Standard Control Organization (CDSCO)’s Drug Controller General of India (DCGI) to proceed with …
Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that it recently submitted a request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of Ocugen’s COVID-19 …
Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that its Chairman, CEO, and Co-Founder, Dr. Shankar Musunuri, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September …
Read More
ST. PETER, MN — The Biden-Harris Administration recently announced that the United States Department of Agriculture (USDA) is making up to $500 million available in grants to help rural health …
Read More
WASHINGTON, D.C. — This week, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow …
Read More
RADNOR, PA — NRx Pharmaceuticals (NRx) (Nasdaq: NRXP) this week announced it is initiating a phase 2b dose-confirmatory trial of the BriLife™ vaccine against COVID-19 in the Nation of Georgia.
Read More PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) this week announced that it has received regulatory allowance for two clinical trials investigating heterologous boosting with INO-4800, its DNA vaccine candidate for COVID-19, …
Read More